Skip to main content
. 2025 Jan 3;25:19. doi: 10.1186/s12879-024-10390-4

Table 2.

Resistance profile of ST11-K64 CRKP strains

Antibiotic agent ST11-K64 CR-KP(n = 36)n(%) non-ST11-K64 CR-KP(n = 33)n(%) P-value
ceftazidime/avibactam 7(19.4) 12(36.3) 0.116
amikacin 35(97.2) 15(45.4) 0.000
gentamicin 35(97.2) 24(72.7) 0.004
tobramycin 35(97.2) 27(81.8) 0.034
sulfamethoxazole 35(97.2) 16(48.4) 0.000
Cefperazone-Sulbactam 35(97.2) 32(96.9) 0.293
piperacillin-tazobactam 36(100) 32(96.9) 0.293
cefepime 36(100) 30(90.9) 0.064
cefoxitin 36(100) 35(97.2) 0.293
aztreonam 36(100) 31(93.9) 0.134
levofloxacin 36(100) 33(100) /
cefazolin 36(100) 33(100) /
ceftriaxone 36(100) 33(100) /
amoxicillin-clavulanic acid 36(100) 33(100) /
ertapenem 36(100) 33(100) /
imipenem 36(100) 33(100) /
ciprofloxacin 36(100) 33(100) /
cefuroxime 36(100) 33(100) /
meropenem 36(100) 33(100) /
ceftazidime 36(100) 33(100) /
piperacillin 36(100) 33(100) /

Bold values in the P-value column indicated statistical significance

HHS Vulnerability Disclosure